| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Talaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 41,000 | 13 Jun 2023 | Direct | ||
| Moderna, Inc. | Director | Restricted Stock Units | 12,174 | 30 Apr 2025 | Direct | ||
| Moderna, Inc. | Director | Stock Option (Right to Buy) | 6,378 | 30 Apr 2025 | Direct | ||
| ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct | ||
| ALEXION PHARMACEUTICALS, INC. | Director | Common Stock, par value $.0001 per share | 0 | $177.00 | 21 Jul 2021 | Direct |